A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain

This study has been terminated.

(Logistic reasons associated with the FDA-imposed clinical hold.)

Sponsor:

Information provided by (Responsible Party):

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

ClinicalTrials.gov Identifier:

NCT00973141

First received: September 4, 2009

Last updated: December 28, 2012

Last verified: December 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2011
Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	July 8, 2011